CA2945049A1 - Composition for arthritis, mobility and delay ageing - Google Patents

Composition for arthritis, mobility and delay ageing Download PDF

Info

Publication number
CA2945049A1
CA2945049A1 CA2945049A CA2945049A CA2945049A1 CA 2945049 A1 CA2945049 A1 CA 2945049A1 CA 2945049 A CA2945049 A CA 2945049A CA 2945049 A CA2945049 A CA 2945049A CA 2945049 A1 CA2945049 A1 CA 2945049A1
Authority
CA
Canada
Prior art keywords
composition
green tea
chondroitin
animal
tea extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2945049A
Other languages
English (en)
French (fr)
Inventor
Samuel SERISIER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mars Inc
Original Assignee
Mars Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mars Inc filed Critical Mars Inc
Publication of CA2945049A1 publication Critical patent/CA2945049A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
CA2945049A 2014-05-23 2015-05-21 Composition for arthritis, mobility and delay ageing Abandoned CA2945049A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP14305772 2014-05-23
EP14305772.7 2014-05-23
GBGB1414910.8A GB201414910D0 (en) 2014-05-23 2014-08-21 Composition
GB1414910.8 2014-08-21
PCT/EP2015/061327 WO2015177309A1 (en) 2014-05-23 2015-05-21 Composition for arthritis, mobility and delay ageing

Publications (1)

Publication Number Publication Date
CA2945049A1 true CA2945049A1 (en) 2015-11-26

Family

ID=50928040

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2945049A Abandoned CA2945049A1 (en) 2014-05-23 2015-05-21 Composition for arthritis, mobility and delay ageing

Country Status (9)

Country Link
US (1) US20170196927A1 (https=)
EP (1) EP3145535A1 (https=)
JP (2) JP2017516757A (https=)
CN (1) CN106413743A (https=)
AU (1) AU2015261792A1 (https=)
CA (1) CA2945049A1 (https=)
GB (1) GB201414910D0 (https=)
RU (1) RU2733403C2 (https=)
WO (1) WO2015177309A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2657434C2 (ru) 2013-05-14 2018-06-13 Марс, Инкорпорейтед Композиция для ухода за суставом
JP2018100238A (ja) * 2016-12-21 2018-06-28 花王株式会社 歩行機能改善剤
US11110147B2 (en) 2017-03-15 2021-09-07 Rousselot B.V Collagen hydrolysates as a beneficial prebiotic and their effect on joint inflammation and osteoarthritis
BE1027357B1 (nl) * 2019-06-12 2021-01-18 Vanlommel Maria Kristel Voedingssupplement voor versnelde genezing

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9425487D0 (en) * 1994-12-16 1995-02-15 Res Inst Osteoarthritis treatment
CA2336602C (en) * 1998-07-07 2010-11-02 Coastside Bio Resources Companion animal therapeutic treat
US7544772B2 (en) * 2001-06-26 2009-06-09 Biomarck Pharmaceuticals, Ltd. Methods for regulating inflammatory mediators and peptides useful therein
US6162787A (en) * 1999-04-02 2000-12-19 Immudyne, Inc. Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions
KR20020011594A (ko) * 2000-08-03 2002-02-09 박종성 콘드로이친, 글루코사민, 신선초분말 등의 기능성소재가함유된 캅셀식품 및 그 제조방법
US20060029647A1 (en) * 2004-02-09 2006-02-09 Friesen Kim G Composition and method for use in cartilage affecting conditions
US20050181047A1 (en) * 2004-02-18 2005-08-18 Jaime Romero Compositions and methods for timed release of water-soluble nutritional supplements
US20060062859A1 (en) * 2004-08-05 2006-03-23 Kenneth Blum Composition and method to optimize and customize nutritional supplement formulations by measuring genetic and metabolomic contributing factors to disease diagnosis, stratification, prognosis, metabolism, and therapeutic outcomes
AU2006248645A1 (en) * 2005-05-20 2006-11-23 Pfizer Limited Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands
AU2006249771A1 (en) * 2005-05-24 2006-11-30 Wellgen, Inc. Compositions and methods for the prevention and treatment of conditions associated with inflammation
WO2008154178A1 (en) * 2007-06-06 2008-12-18 Novus International Inc. Dietary supplements for promotion of growth, repair, and maintenance of bone and joints
EP2106798A1 (en) * 2008-04-02 2009-10-07 Nestec S.A. Sulfated unsaturated disaccharidic chondroitin sulfate in connective tissue protection and repair
US8937194B2 (en) * 2008-12-31 2015-01-20 Nitromega Corp. Topical compositions containing nitro fatty acids
JP5324000B1 (ja) * 2012-03-08 2013-10-23 サントリーホールディングス株式会社 イミダゾールペプチドとケルセチン配糖体を含有する組成物
CN103143002B (zh) * 2013-03-29 2014-12-03 武汉中博绿亚生物科技有限公司 一种用于宠物骨关节的保健剂及其制备方法

Also Published As

Publication number Publication date
JP2020147582A (ja) 2020-09-17
RU2016150516A3 (https=) 2018-11-13
RU2016150516A (ru) 2018-06-26
CN106413743A (zh) 2017-02-15
JP2017516757A (ja) 2017-06-22
WO2015177309A1 (en) 2015-11-26
GB201414910D0 (en) 2014-10-08
RU2733403C2 (ru) 2020-10-01
EP3145535A1 (en) 2017-03-29
AU2015261792A1 (en) 2016-11-03
US20170196927A1 (en) 2017-07-13

Similar Documents

Publication Publication Date Title
Bui et al. Influence of green lipped mussels (Perna canaliculus) in alleviating signs of arthritis in dogs
Olukosi et al. Modification of digesta pH and intestinal morphology with the use of benzoic acid or phytobiotics and the effects on broiler chicken growth performance and energy and nutrient utilization
CA2749280C (en) Methods for improving hepatic and immune function in an animal
EP2996704B1 (en) Joint care composition
EP1687008A2 (en) Food composition comprising glucosamine
JP2020147582A (ja) 関節炎、運動性および老化の遅延のための組成物
KR102936019B1 (ko) 암에 걸린 동물을 지원하기 위한 조성물
CN105682669B (zh) 口服抗寄生虫组合物
AU2024201198B2 (en) Pet food compositions
Gjorgovska et al. Application of rose hip fruits as feed supplement in animal nutrition
JP2012023985A (ja) 飼育動物用動脈硬化抑制飼料
Hossain et al. Evaluation of green tea by-product and green tea plus probiotics on the growth performance, meat quality and immunity of growing–finishing pigs
Mobashar Understanding concepts of feed additives in animal nutrition: their potential in improving livestock production performance and product quality
Boumezrag et al. Modulation of broilers’ productivity and blood biochemical parameters by Citruselements dietary supplementation
HK1230979A1 (en) Composition for arthritis, mobility and delay ageing
Olujimi Evaluating the Dietary Supplementation of Canna indica essential oil on the growth performance and Carcass measurement of broiler chickens
Widjastuti et al. The effects of mangosteen pell extract (Garcinia mangostana L) and minerals as feed suplements usage on performance and gut histology of sentul chicken.
Bahri et al. Journal of Agriculture and Veterinary Science
KR101753244B1 (ko) 트리고넬린을 유효성분으로 포함하는 숙취 해소 및 간기능 개선용 조성물

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20200420

FZDE Discontinued

Effective date: 20220927